Eupraxia Pharmaceuticals (EPRX) Non-Current Assets (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Non-Current Assets of $3.1 million for Q2 2026, up 305.0% from $766,167 a year earlier but down 3.9% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Eupraxia Pharmaceuticals' Non-Current Assets came in at $1.05 million, up 107.9% from FY2024.
- Annual Non-Current Assets shows a three-year compound annual growth rate of 25.4% (FY2022 to FY2025).
- In prior years, Eupraxia Pharmaceuticals' Non-Current Assets was $505,677 in FY2024 (+9.2%), $463,151 in FY2023 (-13.1%) and $533,242 in FY2022.
- Quarterly Non-Current Assets has run from a low of $420,425 in Q1 2024 to a high of $3.23 million in Q1 2026 over five years.
- On a year-over-year basis, Non-Current Assets has increased in each of the last seven quarters, with growth averaging 150.9% over the last seven quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q1 2026, with growth of 415.1%; the weakest was Q4 2023, with a decline of 13.1%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $3.23 million (Q1 2026), $1.05 million (Q4 2025) and $949,192 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 4.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.61 Mn |
| Jun 30, 2026 | 3.10 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 949,192.00 |
| Jun 30, 2025 | 766,167.00 |
| Mar 31, 2025 | 626,767.00 |
| Dec 31, 2024 | 505,677.00 |
| Sep 30, 2024 | 474,923.00 |
| Jun 30, 2024 | 450,128.00 |
| Mar 31, 2024 | 420,425.00 |
| Dec 31, 2023 | 463,151.00 |
| Dec 31, 2022 | 533,242.00 |
API Access
Eupraxia Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();